Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Standardizing wound treatment procedures for advanced technologies.

Gerit D Mulder1

  • 1University of California San Diego Medical Center, Regional Burn Center/Wound Treatment and Research Center, 200 W Arbor Dr 8896, San Diego, CA 92103-8896, USA.

Journal of the American Podiatric Medical Association
|January 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies.

Wounds : a compendium of clinical research and practice·2017
Same author

Polyhexamethylene Biguanide (PHMB): An Addendum to Current Topical Antimicrobials.

Wounds : a compendium of clinical research and practice·2015
Same author

Stem cell applications in diabetic charcot foot and ankle reconstructive surgery .

Wounds : a compendium of clinical research and practice·2015
Same author

Comprehensive review of the clinical application of autologous mesenchymal stem cells in the treatment of chronic wounds and diabetic bone healing.

International wound journal·2012
Same author

Hallux, sesamoid, and first metatarsal injuries.

Clinics in podiatric medicine and surgery·2011
Same author

Foot and ankle surgery: considerations for the geriatric patient.

Journal of the American Board of Family Medicine : JABFM·2009
Same journal

Offloading Adherence for Appearance's Sake?

Journal of the American Podiatric Medical Association·2026
Same journal

Effect of Insoles on Plantar Fascia Tension During Running in Individuals with Flatfoot.

Journal of the American Podiatric Medical Association·2026
Same journal

Reducing Lower Extremity Amputations via Peer Support Interventions: A Scoping Review.

Journal of the American Podiatric Medical Association·2026
Same journal

Quantitative Assessment of the Correlation Between 'COVID Toes' Search Volume and COVID-19 Case Incidence and Mortality Dynamics: A Longitudinal Data-Driven Approach.

Journal of the American Podiatric Medical Association·2026
Same journal

Reconsidering Nerve Decompression Surgery in Diabetes Foot Complications.

Journal of the American Podiatric Medical Association·2026
Same journal

Quantification of the Mechanical Response of the Plantar Fascia to Changes in Rearfoot Position.

Journal of the American Podiatric Medical Association·2026
See all related articles

This article details a standardized procedure for using recombinant human platelet-derived growth factor (rhPDGF-BB) for chronic wound treatment. It emphasizes clinical support for off-label use of topical growth factors in wound care.

Area of Science:

  • Regenerative Medicine
  • Wound Healing Biology

Background:

  • Chronic wounds pose significant clinical challenges.
  • Novel therapeutic agents, including growth factors and tissue replacements, are emerging for wound management.

Purpose of the Study:

  • To outline a standardized procedure for topical application of recombinant human platelet-derived growth factor-BB (rhPDGF-BB).
  • To guide clinicians on the integration of rhPDGF-BB into chronic wound treatment regimens.

Main Methods:

  • Focus on a specific growth factor: rhPDGF-BB.
  • Topical administration route.
  • Standardized procedural recommendations.

Main Results:

  • Integration of rhPDGF-BB into treatment protocols.

Related Experiment Videos

  • Potential for improved chronic wound healing.

    • Conclusions:

    • Clinicians should follow standardized procedures for rhPDGF-BB use.
    • Off-label indications require clinical justification.
    • rhPDGF-BB represents a key advancement in chronic wound therapy.